Osteoclasts direct bystander killing of cancer cells in vitro

Bone

Volumn 38, Issue 1, 2006, Pages 4-12

  Ramnaraine, Margaret ^a   Pan, Weihong ^a   Clohisy, Denis R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bone metastasis; Breast cancer; Osteoclasts

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; NERVE GROWTH FACTOR RECEPTOR; RETROVIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; COCULTURE; CONTROLLED STUDY; FUSION GENE; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOCLAST; SARCOMA CELL; STEM CELL;

ANIMALS; ANTIMETABOLITES, ANTINEOPLASTIC; BONE MARROW CELLS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE, TUMOR; COCULTURE TECHNIQUES; CYTOSINE DEAMINASE; FLOW CYTOMETRY; FLUCYTOSINE; FLUOROURACIL; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; NIH 3T3 CELLS; OSTEOCLASTS; RECEPTOR, NERVE GROWTH FACTOR; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; SACCHAROMYCES CEREVISIAE; SARCOMA; TRANSDUCTION, GENETIC;

EID: 29344438820     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2005.07.016     Document Type: Article

References (32)

1. V. Barresi, N. Belluardo, S. Sipione, G. Mudo, E. Cattaneo, and D.F. Condorelli Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy Cancer Gene Ther. 10 5 2003 396 402
2. G.A. Chung-Faye, M.J. Chen, N.K. Green, A. Burton, D. Anderson, and V. Mautner In vivo gene therapy for colon cancer using adenovirusmediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferase Gene Ther. 8 2001 1547 1554
3. P. Erbs, E. Regulier, J. Kintz, P. Leroy, Y. Poitevin, and F. Exinger In vivo cancer Gene Therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene Cancer Res. 60 2000 3813 3822
4. O. Greco, and G.U. Dachs Gene directed enzyme/prodrug therapy of cancer: historical appraisal and future prospectives J. Cell. Physiol. 187 2001 22 36
5. D. Kirn, I. Niculescu-Duvaz, G. Hallden, and C.J. Springer The emerging fields of suicide gene therapy and virotherapy Trends Mol. Med. 8 2002 S68 S73
6. M. Ramnaraine, W. Pan, M. Goblirsch, C. Lynch, V. Lewis, and P. Orchard Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene Can. Res. 63 2003 6847 6854
7. J. Wei, S. Blum, M. Unger, G. Jarmy, M. Lamparter, and A. Geishauser Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery Cancer Cells 5 2004 477 488
8. B.E. Huber, E.A. Austin, C.A. Richards, S.T. Davis, and S.S. Good Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase Proc. Natl. Acad. Sci. U. S. A. 91 1994 8302 8306
9. E. Kievit, M.K. Nyati, E. Ng, L.D. Stegman, J. Parsels, and B.D. Ross Yeast cytosine deaminase improves radiosensitization and bystander effect by 5-fluorocytosine of human colorectal cancer xenografts Cancer Res. 60 2000 6649 6655
10. S. Benedetti, B. Pirola, B. Pollo, L. Magrassi, M.G. Bruzzone, and D. Rigamonti Gene Therapy of experimental brain tumors using neural progenitor cells Nat. Med. 6 2000 447 450
11. T. Asahara, H. Masuda, T. Takahashi, C. Kalka, C. Pastore, and M. Silver Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ. Res. 85 1999 221 228
12. J.M. Chirgwin, and T.A. Guise Molecular mechanisms of tumor-bone interactions in osteolytic metastases Crit. Rev. Eukaryot. Gene Expr. 10 2 2000 159 178
13. S.M. Kakonen, and G.R. Mundy Mechanisms of osteolytic bone metastases in breast carcinoma Cancer 97 2003 834 839
14. A. Lipton Pathophysiology of bone metastases: how this knowledge may lead to therapeutic intervention J. Support Oncol. 2 3 2004 205 213
15. G.D. Roodman Mechanisms of bone metastasis N. Engl. J. Med. 350 2004 1655 1664
16. P. Ralph, and I. Nakoinz Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS J. Immunol. 119 1977 950 954
17. P. Collin-Osdoby, X. Yu, H. Zheng, and P. Osdoby RANKL-mediated osteoclast formation from murine RAW 264.7 cells Methods Mol. Med. 80 2003 153 166
18. C.J. Aslakson, and F.R. Miller Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor Cancer Res. 52 1992 1399 1405
19. J.H. Harmey, C.D. Bucana, W. Lu, A.M. Byrne, S. McDonnell, and C. Lynch Lipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasion Int. J. Cancer 101 2002 415 422
20. Z. Ivics, P.B. Hackett, R.H. Plasterk, and Z. Izsvak Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells Cell 91 1997 501 510
21. V.A. Lewis, L. Basso, N. Blake, J. Salo, T.C. Lund, and R.S. McIvor Human nerve growth factor receptor and cytosine deaminase fusion genes Hum. Gene Ther. 14 2003 1009 1016
22. P.D. Senter, P.C.D. Su, T. Katsuragi, T. Sakai, W.L. Cosand, and I. Hellstrom Generation of 5-fluorouracil from 5-fluorocytosine by monoclonal antibody-cytosine deaminase conjugates Bioconj. Chem. 2 1991 447 451
23. W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, and R. Lüthy Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
24. W. Pan, W. Mathews, J.M. Donohue, M.L. Ramnaraine, C. Lynch, and D. Selski Analysis of distinct tartrate-resistant acid phosphatase promoter regions in transgenic mice J. Biol. Chem. 280 6 2005 4888 4893
25. E. Kievit, E. Bershad, E. Ng, P. Sethna, I. Dev, and T.S. Lawrence Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts Cancer Res. 59 1999 1417 1421
26. D.R. Clohisy, C.M. Ogilvie, R.J. Carpenter, and M.L. Ramnaraine Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts J. Orthop. Res. 14 1996 2 6
27. G.R. Mundy Metastasis to bone: causes. consequences and therapeutic opportunities Nat. Rev. Cancer 2 2002 584 593
28. T. Hiraga, P.J. Williams, A. Ueda, D. Tamura, and T. Yoneda Zoledronic acid inhibits visceral metastases in the 4T1/luc mouse breast cancer model Clin. Cancer Res. 10 2004 4559 4567
29. T. Yoneda, T. Michigami, B. Yi, P.J. Williams, M. Niewolna, and T. Hiraga Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma Cancer 88 2000 2979
30. L.S. Rosen, D.H. Gordon, W. Dugan Jr., P. Major, P.D. Eisenberg, and L. Provencher Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion Cancer 100 1 2004 36 43
31. A. Lipton, R.L. Theriault, G.N. Hortobagyi, J. Simeone, R.D. Knight, and K. Mellars Pamidronate prevents skeletal complications and is effective palliative treatment in women with breast carcinoma and osteolytic bone metastases: long term follow-up of two randomized, placebo-controlled trials Cancer 88 2000 1082 1090
32. R.L. Theriault, A. Lipton, G.N. Hortobagyi, R. Leff, S. Gluck, and J.F. Stewart Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: a randomized, placebo-controlled trial. Protocol 18 Aredia Breast Cancer Study Group J. Clin. Oncol. 17 3 1999 846 854